William Ciambrone
2021
Compensation breakdown
| Non-Equity Incentive Plan | $270,100 |
|---|---|
| Option Awards | $2,959,290 |
| Salary | $494,092 |
| Stock Awards | $1,306,650 |
| Other | $16,089 |
| Total | $5,046,221 |
Ciambrone received $3M in option awards, accounting for 59% of the total pay in 2021.
Ciambrone also received $270.1K in non-equity incentive plan, $494.1K in salary, $1.3M in stock awards and $16.1K in other compensation.
Rankings
In 2021, William Ciambrone's compensation ranked 2,594th out of 12,415 executives tracked by ExecPay. In other words, Ciambrone earned more than 79.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,594 out of 12,415 | 79th |
Division Manufacturing | 1,027 out of 5,505 | 81st |
Major group Chemicals And Allied Products | 398 out of 2,375 | 83rd |
Industry group Drugs | 349 out of 2,096 | 83rd |
Industry Pharmaceutical Preparations | 229 out of 1,546 | 85th |
Pay ratio
| William Ciambrone's Pay | $5,046,221 |
|---|---|
| Median Employee's Pay | $271,908 |
| Pay Ratio | 19to 1 |
In 2021, the annual total compensation of William Ciambrone was $5,046,221.
The annual total compensation of the median employee at Sarepta Therapeutics was $271,908.
The ratio of William Ciambrone's pay to the pay of median employee was therefore 19 to one.
Ciambrone's colleagues
We found four more compensation records of executives who worked with William Ciambrone at Sarepta Therapeutics in 2021.